{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T03:14:51Z","timestamp":1771125291346,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.encep.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:18:38Z","timestamp":1746429518000},"page":"539-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment strategies for clozapine-induced sialorrhea in France: A systematic review"],"prefix":"10.1016","volume":"51","author":[{"given":"Am\u00e9lie","family":"Rousseau-Voisin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Javelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Lach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Yrondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Egron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Foclher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Gohier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Bottemanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2025.02.004_bib0575","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1345\/aph.1P761","article-title":"Current treatment strategies for clozapine-induced sialorrhea","volume":"45","author":"Bird","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2025.02.004_bib0580","series-title":"The Cochrane Collaboration. Cochrane Database Syst Rev","article-title":"Pharmacological interventions for clozapine-induced hypersalivation","author":"Syed","year":"2008"},{"key":"10.1016\/j.encep.2025.02.004_bib0585","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2045125316641019","article-title":"Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life","volume":"6","author":"Maher","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0590","first-page":"817","article-title":"Adverse drug reactions in relation to clozapine plasma levels: a systematic review","volume":"15","author":"Skokou","year":"2022","journal-title":"Pharm Basel Switz"},{"key":"10.1016\/j.encep.2025.02.004_bib0595","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-022-06294-3","article-title":"Prevalence of clozapine-induced sialorrhea and its effect on quality of life","volume":"240","author":"Sanagustin","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2025.02.004_bib0600","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0605","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2010.02.1060","article-title":"Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study","volume":"119","author":"Liang","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2025.02.004_bib0610","first-page":"11","article-title":"Schizophrenia past clozapine: reasons for clozapine discontinuation, mortality, and alternative antipsychotic prescribing","volume":"48","author":"Mustafa","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0615","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3371\/CSRP.SAFI.061213","article-title":"Aspiration pneumonia due to clozapine-induced sialorrhea","volume":"9","author":"Saenger","year":"2016","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.encep.2025.02.004_bib0620","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2009.03.002","article-title":"Increased use of antibiotics in patients treated with clozapine","volume":"19","author":"Nielsen","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0625","unstructured":"Roth BL, Driscol J. \u201cPDSP Ki Database\u201d. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. n.d."},{"key":"10.1016\/j.encep.2025.02.004_bib0630","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0248-4","article-title":"Clozapine-induced sialorrhea: pathophysiology and management strategies","volume":"185","author":"Praharaj","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2025.02.004_bib0635","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00004714-200112000-00012","article-title":"Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study","volume":"21","author":"Bai","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0640","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.stemcr.2021.09.015","article-title":"(-Adrenergic signaling induces Notch-mediated salivary gland progenitor cell control","volume":"16","author":"Wang","year":"2021","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.encep.2025.02.004_bib0645","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-199202000-00026","article-title":"Clonidine treatment of clozapine-induced hypersalivation","volume":"12","author":"Grabowski","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0650","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.encep.2022.03.013","article-title":"Prise en charge de l\u2019hypersialorrh\u00e9e iatrog\u00e8ne: revue de la litt\u00e9rature et recommandations pratiques","volume":"48","author":"Cuvelier","year":"2022","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.encep.2025.02.004_bib0655","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.encep.2025.02.004_bib1000","first-page":"250","article-title":"Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect","volume":"24","author":"Antonello","year":"1999","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.encep.2025.02.004_bib1005","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/000486700285","article-title":"Use of atropine eye drops for clozapine induced hypersalivation","volume":"34","author":"Comley","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0665","first-page":"253","article-title":"Clozapine and sialorrhea: update","volume":"26","author":"Tessier","year":"2001","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.encep.2025.02.004_bib1010","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1345\/aph.1E077","article-title":"Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea","volume":"38","author":"Sharma","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2025.02.004_bib1015","first-page":"236","article-title":"Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea","volume":"16","author":"Mustafa","year":"2013","journal-title":"Afr J Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib1020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2045125315591926","article-title":"A natural study of the efficacy of replacement medications for the treatment of clozapine-induced hypersalivation","volume":"6","author":"Chu","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0670","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.schres.2016.10.039","article-title":"Sublingual atropine in the treatment of clozapine-induced sialorrhea","volume":"182","author":"Matos Santana","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2025.02.004_bib1025","first-page":"757","article-title":"Comparing the impact of atropine drops and amitriptyline tablets in treatment of clozapine-induced sialorrhea: a randomized double-blind placebo controlled clinical trial","author":"Sheikhmoonesi","year":"2018","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.encep.2025.02.004_bib1030","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/ccr3.2431","article-title":"The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: a systematic review","volume":"7","author":"Van der Poorten","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.encep.2025.02.004_bib0660","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s00213-020-05627-4","article-title":"The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial","volume":"237","author":"Mubaslat","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2025.02.004_bib1035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5152\/pcp.2022.21221","article-title":"Pharmacokinetics and effects on saliva flow of sublingual and oral atropine in clozapine-treated and healthy adults: an interventional cross-over study","volume":"32","author":"Sydney Medical School","year":"2022","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1040","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.pnpbp.2007.06.013","article-title":"Glycopyrrolate for clozapine-induced sialorrhea","volume":"31","author":"Duggal","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0680","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/cap.2007.0037","article-title":"Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents","volume":"18","author":"Robb","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0685","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2146\/ajhp130636","article-title":"Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults","volume":"71","author":"Blissit","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.encep.2025.02.004_bib0690","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/JCP.0000000000000102","article-title":"Low-dose glycopyrrolate for clozapine-associated sialorrhea","volume":"34","author":"Praharaj","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0695","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/JCP.0000000000000657","article-title":"The effect of glycopyrrolate on nocturnal sialorrhea in patients using clozapine: a randomized, crossover, double-blind, placebo-controlled trial","volume":"37","author":"Man","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0700","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40814-019-0462-1","article-title":"Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study","volume":"5","author":"Qurashi","year":"2019","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.encep.2025.02.004_bib0705","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_552_21","article-title":"Cessation of clozapine-induced severe hypersalivation along with improvement of residual persistent auditory hallucinations by tDCS in a patient of chronic schizophrenia - A case report","volume":"64","author":"Astha","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib1045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1192\/pb.25.7.277-c","article-title":"Hyoscine patches in clozapine-induced hypersalivation","volume":"25","author":"McKane","year":"2001","journal-title":"Psychiatr Bull"},{"key":"10.1016\/j.encep.2025.02.004_bib0710","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/appi.ps.55.3.318","article-title":"Scolpolamine patch for clozapine-induced sialorrhea","volume":"55","author":"Gaftanyuk","year":"2004","journal-title":"Psychiatr Serv Wash DC"},{"key":"10.1016\/j.encep.2025.02.004_bib0715","doi-asserted-by":"crossref","first-page":"109","DOI":"10.9758\/cpn.2015.13.1.109","article-title":"Effect of scopolamine butylbromide on clozapine-induced hypersalivation in schizophrenic patients: a case series","volume":"13","author":"Takeuchi","year":"2015","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.encep.2025.02.004_bib1050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/JCP.0000000000000613","article-title":"Scopolamine ointment for clozapine-associated sialorrhea: a case report","volume":"37","author":"Goto","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1055","doi-asserted-by":"crossref","first-page":"e12269","DOI":"10.1111\/appy.12269","article-title":"Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: a preliminary study: Treatment of clozapine-induced hypersalivation","volume":"9","author":"Takeuchi","year":"2017","journal-title":"Asia-Pac Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0720","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YIC.0000000000000251","article-title":"Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial","volume":"34","author":"Segev","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0730","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200015010-00008","article-title":"Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report","volume":"15","author":"Calderon","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0735","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.jcp.0000106228.36344.2e","article-title":"Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series","volume":"24","author":"Freudenreich","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0725","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.08m04495","article-title":"Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study","volume":"70","author":"Sockalingam","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0740","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004850-199707000-00005","article-title":"Trihexyphenidyl treatment of clozapine-induced hypersalivation","volume":"12","author":"Spivak","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-199603000-00010","article-title":"Trihexyphenidyl as a possible therapeutic option in clozapine-induced nocturnal enuresis","volume":"11","author":"Poyurovsky","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0019-5359.57642","article-title":"Trihexyphenidyl (benzhexol) in clozapine-induced nocturnal enuresis and sialorrhea","volume":"63","author":"Aggarwal","year":"2009","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib1070","first-page":"73","article-title":"Complete resolution of clozapine-induced sialorrhea with low dose trihexyphenidyl","volume":"43","author":"Praharaj","year":"2010","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.encep.2025.02.004_bib1075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1192\/bjp.159.1.166a","article-title":"Amitriptyline in clozapine-induced sialorrhoea","volume":"159","author":"Copp","year":"1991","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib0745","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2125.2006.02748.x","article-title":"Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea","volume":"63","author":"Praharaj","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0750","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/1574886311666160426130252","article-title":"Very low dose amitriptyline for clozapine-associated sialorrhea","volume":"11","author":"Sinha","year":"2016","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.encep.2025.02.004_bib0755","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2022.02.035","article-title":"Amitriptyline for clozapine-induced hypersalivation: a case series","volume":"243","author":"Cereda","year":"2022","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2025.02.004_bib0760","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1345\/aph.1Q270","article-title":"Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea","volume":"45","author":"Leung","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2025.02.004_bib1080","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.158.8.1329-a","article-title":"Biperiden for excessive sweating from clozapine","volume":"158","author":"Richardson","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0770","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/24750573.2017.1347601","article-title":"Tropicamide ophthalmic solution reduces clozapine-induced sialorrhea: a case report","volume":"27","author":"Kilic","year":"2017","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0775","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0269881105053311","article-title":"Is clonidine useful for treatment of clozapine-induced sialorrhea?","volume":"19","author":"Praharaj","year":"2005","journal-title":"J Psychopharmacol (Oxf)"},{"key":"10.1016\/j.encep.2025.02.004_bib1085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.9740\/mhc.2020.01.034","article-title":"Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea","volume":"10","author":"Leung","year":"2020","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.encep.2025.02.004_bib1090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00044011-199917020-00003","article-title":"Comparative efficacy and tolerability of benzatropine and terazosin in the treatment of hypersalivation secondary to clozapine","volume":"17","author":"Reinstein","year":"1999","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.encep.2025.02.004_bib0780","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/2045125312455187","article-title":"A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review","volume":"2","author":"Immadisetty","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0820","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2005-837771","article-title":"Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation","volume":"38","author":"Croissant","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0785","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.yic.0000188216.92408.69","article-title":"Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study","volume":"21","author":"Kreinin","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/JCP.0b013e318199f264","article-title":"Amisulpride treatment for clozapine-induced sialorrhea","volume":"29","author":"Praharaj","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0825","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/MJT.0b013e3181c84bbd","article-title":"Amisulpride improved debilitating clozapine-induced sialorrhea","volume":"18","author":"Praharaj","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.encep.2025.02.004_bib0790","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/15622975.2010.527370","article-title":"Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation","volume":"12","author":"Kreinin","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib1100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/0253-7176.168592","article-title":"Low-dose amisulpride for debilitating clozapine-induced sialorrhea: case series and review of literature","volume":"37","author":"Kulkarni","year":"2015","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.encep.2025.02.004_bib1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/408179","article-title":"Amisulpride augmentation for clozapine-refractory positive symptoms: additional benefit in reducing hypersialorrhea","volume":"2015","author":"Bogorni","year":"2015","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0840","first-page":"61","article-title":"Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study","volume":"42","author":"Kreinin","year":"2005","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib1110","first-page":"1230","article-title":"Clozapine-induced hypersalivation treated with sulpiride-is it a solution?","volume":"33","author":"Prlja\u010da","year":"2021","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.encep.2025.02.004_bib0845","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/JCP.0000000000000493","article-title":"Double-blind, randomized, placebo-controlled trial of metoclopramide for hypersalivation associated with clozapine","volume":"36","author":"Kreinin","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12888-022-03940-0","article-title":"A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)","volume":"22","author":"Livermore","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0870","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WNF.0b013e31818f1111","article-title":"Moclobemide treatment of clozapine-induced hypersalivation: pilot open study","volume":"32","author":"Kreinin","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0880","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.pnpbp.2009.09.014","article-title":"Clozapine-induced sialorrhea alleviated by bupropion \u2014 A case report","volume":"33","author":"Stern","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0890","article-title":"Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series","author":"Uzun","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0910","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-004-1803-0","article-title":"Botulinum toxin as an effective treatment of clozapine-induced hypersalivation","volume":"173","author":"Kahl","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2025.02.004_bib0920","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-017-4795-2","article-title":"Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea","volume":"235","author":"Verma","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2025.02.004_bib0915","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","article-title":"Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea","volume":"207","author":"Steinlechner","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2025.02.004_bib0925","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaclp.2021.05.002","article-title":"Early use of botulinum neurotoxin treatment for clozapine-induced sialorrhea","volume":"62","author":"Moss","year":"2021","journal-title":"J Acad Consult-Liaison Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0955","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00044011-200323010-00008","article-title":"Use of quetiapine to manage patients who experienced adverse effects with clozapine","volume":"23","author":"Reinstein","year":"2003","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.encep.2025.02.004_bib0675","first-page":"148","article-title":"Pharmacological effects of some newly developed soft anticholinergics and a receptor-binding QSAR study","volume":"61","author":"Mori","year":"2006","journal-title":"Pharm"},{"key":"10.1016\/j.encep.2025.02.004_bib1120","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0024-3205(99)00188-5","article-title":"Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland","volume":"64","author":"Moriya","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib1125","article-title":"Muscarinic M1 and M2 receptors, fasting and seizure development in animals","author":"Bacanak","year":"2018","journal-title":"Clin Exp Health Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib1130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2008.12.043","article-title":"Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist","volume":"605","author":"McNamara","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine\u2013a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib1140","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/10799899509049862","article-title":"Actions of terazosin and its enantiomers at subtypes of \u03b1- and \u03b12-Adrenoceptors in vitro","volume":"15","author":"Hancock","year":"1995","journal-title":"J Recept Signal Transduct"},{"key":"10.1016\/j.encep.2025.02.004_bib0765","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0026-895X(25)09592-6","article-title":"Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells","volume":"38","author":"Lazareno","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0795","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.encep.2025.02.004_bib0800","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.encep.2025.02.004_bib0805","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2004-815471","article-title":"Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature","volume":"37","author":"Zink","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0810","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.euroneuro.2011.08.005","article-title":"Clozapine resistance: augmentation strategies","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0815","first-page":"CD006324","article-title":"Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia","volume":"3","author":"Barber","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.encep.2025.02.004_bib0830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01983482","article-title":"Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats","volume":"42","author":"Desai","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.encep.2025.02.004_bib0835","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00365521.1976.12097069","article-title":"Inhibition of sulpiride on the cephalic phase of gastric acid and gastrin secretion in duodenal ulcer patients","volume":"11","author":"Lam","year":"1976","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.encep.2025.02.004_bib0850","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0000000000001655","article-title":"Treatment of clozapine-associated sialorrhea: the role of benzamide derivatives","volume":"43","author":"Miodownik","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0855","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2165\/00003088-199631050-00005","article-title":"Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease","volume":"31","author":"Hatlebakk","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.encep.2025.02.004_bib0860","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pnpbp.2017.12.012","article-title":"Meta-analysis: Risk of dry mouth with second generation antidepressants","volume":"84","author":"Cappetta","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0865","first-page":"214","article-title":"Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide","volume":"18","author":"Nair","year":"1993","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.encep.2025.02.004_bib0875","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults: anticholinergic activity of medication","volume":"56","author":"Chew","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.encep.2025.02.004_bib0885","doi-asserted-by":"crossref","first-page":"105951","DOI":"10.1016\/j.clineuro.2020.105951","article-title":"Relationships of drooling with motor symptoms and dopamine transporter imaging in drug-na\u00efve Parkinson's disease","volume":"195","author":"Mito","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.encep.2025.02.004_bib0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6581970","article-title":"Effect of N-acetylcysteine on antioxidant defense, oxidative modification, and salivary gland function in a rat model of insulin resistance","volume":"2018","author":"\u017bukowski","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.encep.2025.02.004_bib0900","doi-asserted-by":"crossref","first-page":"e2769","DOI":"10.1002\/hup.2769","article-title":"Could N-acetylcysteine improve the safety of clozapine?","volume":"36","author":"Chr\u00e9tien","year":"2021","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0905","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(01)00565-2","article-title":"Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis","volume":"190","author":"Tan","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib0930","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","article-title":"Clozapine is a potent and selective muscarinic M4 receptor agonist","volume":"269","author":"Zorn","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0935","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","article-title":"Drug effects on salivary glands: dry mouth: drug effects on salivary glands: dry mouth","volume":"9","author":"Scully Cbe","year":"2003","journal-title":"Oral Dis"},{"key":"10.1016\/j.encep.2025.02.004_bib0940","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0447.2004.00356.x","article-title":"Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine","volume":"110","author":"Munro","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.encep.2025.02.004_bib0945","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamapsychiatry.2018.4320","article-title":"Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia","volume":"76","author":"Tiihonen","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0950","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40265-021-01556-4","article-title":"Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations","volume":"81","author":"L\u00e4hteenvuo","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.encep.2025.02.004_bib0960","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.12912","article-title":"Salivary secretory disorders, inducing drugs, and clinical management","volume":"12","author":"Miranda-Rius","year":"2015","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.encep.2025.02.004_bib0965","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/02537176211025789","article-title":"Review of psychotropic agents associated with sialorrhoea, except clozapine","volume":"45","author":"Halder","year":"2023","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.encep.2025.02.004_bib0970","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5414\/CP204538","article-title":"Effectiveness of atropine in managing sialorrhea: a systematic review and meta-analysis","volume":"62","author":"Yellepeddi","year":"2024","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.encep.2025.02.004_bib0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.08.004","article-title":"A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation","author":"Mutlu","year":"2023","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2025.02.004_bib0980","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/ccr3.2431","article-title":"The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic review","volume":"7","author":"Van Der Poorten","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.encep.2025.02.004_bib0985","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.euroneuro.2016.08.004","article-title":"Systematic prevention of severe constipation induced by antipsychotic agents: A quasi-experimental study","volume":"26","author":"Bulot","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2025.02.004_bib0990","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1038\/s41380-023-02266-x","article-title":"Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials","volume":"28","author":"Fornaro","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.encep.2025.02.004_bib0995","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40263-019-00612-8","article-title":"Treatment strategies for clozapine-induced sialorrhea: a systematic review and meta-analysis","volume":"33","author":"Chen","year":"2019","journal-title":"CNS Drugs"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700625000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700625000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:57:16Z","timestamp":1757995036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700625000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0013700625000922"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2025.02.004","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategies for clozapine-induced sialorrhea in France: A systematic review","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}